These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 15698782)
1. Synthesis and anti-viral activity of a series of d- and l-2'-deoxy-2'-fluororibonucleosides in the subgenomic HCV replicon system. Shi J; Du J; Ma T; Pankiewicz KW; Patterson SE; Tharnish PM; McBrayer TR; Stuyver LJ; Otto MJ; Chu CK; Schinazi RF; Watanabe KA Bioorg Med Chem; 2005 Mar; 13(5):1641-52. PubMed ID: 15698782 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and in vitro anti-HCV activity of beta-D- and 1-2'-deoxy-2'-fluororibonucleosides. Shi J; Du J; Ma T; Pankiewicz KW; Patterson SE; Hassan AE; Tharnish PM; McBrayer TR; Lostia S; Stuyver LJ; Watanabe KA; Chu CK; Schinazi RF; Otto MJ Nucleosides Nucleotides Nucleic Acids; 2005; 24(5-7):875-9. PubMed ID: 16248053 [TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, and antiviral activity of 2'-deoxy-2'-fluoro-2'-C-methylcytidine, a potent inhibitor of hepatitis C virus replication. Clark JL; Hollecker L; Mason JC; Stuyver LJ; Tharnish PM; Lostia S; McBrayer TR; Schinazi RF; Watanabe KA; Otto MJ; Furman PA; Stec WJ; Patterson SE; Pankiewicz KW J Med Chem; 2005 Aug; 48(17):5504-8. PubMed ID: 16107149 [TBL] [Abstract][Full Text] [Related]
4. Establishment of a subgenomic replicon for bovine viral diarrhea virus in Huh-7 cells and modulation of interferon-regulated factor 3-mediated antiviral response. Horscroft N; Bellows D; Ansari I; Lai VC; Dempsey S; Liang D; Donis R; Zhong W; Hong Z J Virol; 2005 Mar; 79(5):2788-96. PubMed ID: 15708997 [TBL] [Abstract][Full Text] [Related]
5. Suppression of subgenomic hepatitis C virus replication by 5'-O-masked analogues of 6-chloropurine-2'-deoxyriboside. Ikejiri M; Ohshima T; Kato K; Toyama M; Murata T; Shimotohno K; Maruyama T Nucleic Acids Symp Ser (Oxf); 2007; (51):439-40. PubMed ID: 18029775 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and antiviral activity of 2'-deoxy-2'-fluoro-2'-C-methyl purine nucleosides as inhibitors of hepatitis C virus RNA replication. Clark JL; Mason JC; Hollecker L; Stuyver LJ; Tharnish PM; McBrayer TR; Otto MJ; Furman PA; Schinazi RF; Watanabe KA Bioorg Med Chem Lett; 2006 Mar; 16(6):1712-5. PubMed ID: 16368235 [TBL] [Abstract][Full Text] [Related]
7. Antiviral 2,5-disubstituted imidazo[4,5-c]pyridines: from anti-pestivirus to anti-hepatitis C virus activity. Puerstinger G; Paeshuyse J; De Clercq E; Neyts J Bioorg Med Chem Lett; 2007 Jan; 17(2):390-3. PubMed ID: 17084081 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and anti-viral activity of a series of sesquiterpene lactones and analogues in the subgenomic HCV replicon system. Hwang DR; Wu YS; Chang CW; Lien TW; Chen WC; Tan UK; Hsu JT; Hsieh HP Bioorg Med Chem; 2006 Jan; 14(1):83-91. PubMed ID: 16140536 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and anti-HCV activity of 2',5'-deoxy-5'-phenacyladenosine analogs. Ikejiri M; Ohshima T; Fukushima A; Shimotohno K; Maruyama T Nucleic Acids Symp Ser (Oxf); 2009; (53):103-4. PubMed ID: 19749281 [TBL] [Abstract][Full Text] [Related]
10. Synthesis of beta-enantiomers of N4-hydroxy-3'-deoxypyrimidine nucleosides and their evaluation against bovine viral diarrhoea virus and hepatitis C virus in cell culture. Hollecker L; Choo H; Chong Y; Chu CK; Lostia S; McBrayer TR; Stuyver LJ; Mason JC; Du J; Rachakonda S; Shi J; Schinazi RF; Watanabe KA Antivir Chem Chemother; 2004 Jan; 15(1):43-55. PubMed ID: 15074714 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and anti-HCV activity of β-d-2'-deoxy-2'-α-chloro-2'-β-fluoro and β-d-2'-deoxy-2'-α-bromo-2'-β-fluoro nucleosides and their phosphoramidate prodrugs. Ovadia R; Khalil A; Li H; De Schutter C; Mengshetti S; Zhou S; Bassit L; Coats SJ; Amblard F; Schinazi RF Bioorg Med Chem; 2019 Feb; 27(4):664-676. PubMed ID: 30655167 [TBL] [Abstract][Full Text] [Related]
12. The design, synthesis, and antiviral activity of 4'-azidocytidine analogues against hepatitis C virus replication: the discovery of 4'-azidoarabinocytidine. Smith DB; Kalayanov G; Sund C; Winqvist A; Pinho P; Maltseva T; Morisson V; Leveque V; Rajyaguru S; Le Pogam S; Najera I; Benkestock K; Zhou XX; Maag H; Cammack N; Martin JA; Swallow S; Johansson NG; Klumpp K; Smith M J Med Chem; 2009 Jan; 52(1):219-23. PubMed ID: 19055482 [TBL] [Abstract][Full Text] [Related]
13. In vitro antiviral activity of SCH446211 (SCH6), a novel inhibitor of the hepatitis C virus NS3 serine protease. Liu R; Abid K; Pichardo J; Pazienza V; Ingravallo P; Kong R; Agrawal S; Bogen S; Saksena A; Cheng KC; Prongay A; Njoroge FG; Baroudy BM; Negro F J Antimicrob Chemother; 2007 Jan; 59(1):51-8. PubMed ID: 17151003 [TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, and anti-HCV activity of thiourea compounds. Kang IJ; Wang LW; Lee CC; Lee YC; Chao YS; Hsu TA; Chern JH Bioorg Med Chem Lett; 2009 Apr; 19(7):1950-5. PubMed ID: 19251415 [TBL] [Abstract][Full Text] [Related]
15. Synthesis of benzodithiol-2-yl-substituted nucleoside derivatives as lead compounds having anti-bovine viral diarrhea virus activity. Seio K; Sasaki T; Yanagida K; Baba M; Sekine M J Med Chem; 2004 Oct; 47(21):5265-75. PubMed ID: 15456271 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and anti-hepatitis C virus (HCV) activity of 3'-C-substituted-methyl pyrimidine and purine nucleosides. Choi WJ; Kim YM; Kim HO; Lee HW; Kim DE; Park KS; Chong Y; Jeong LS Bioorg Med Chem; 2010 Jul; 18(13):4812-20. PubMed ID: 20627592 [TBL] [Abstract][Full Text] [Related]
17. High-throughput screening of HCV RNA replication inhibitors by means of a reporter replicon system. Hao W; Duggal R Methods Mol Biol; 2009; 510():243-50. PubMed ID: 19009266 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of hepatitis C replicon RNA synthesis by beta-D-2'-deoxy-2'-fluoro-2'-C-methylcytidine: a specific inhibitor of hepatitis C virus replication. Stuyver LJ; McBrayer TR; Tharnish PM; Clark J; Hollecker L; Lostia S; Nachman T; Grier J; Bennett MA; Xie MY; Schinazi RF; Morrey JD; Julander JL; Furman PA; Otto MJ Antivir Chem Chemother; 2006; 17(2):79-87. PubMed ID: 17042329 [TBL] [Abstract][Full Text] [Related]
19. The non-immunosuppressive cyclosporin DEBIO-025 is a potent inhibitor of hepatitis C virus replication in vitro. Paeshuyse J; Kaul A; De Clercq E; Rosenwirth B; Dumont JM; Scalfaro P; Bartenschlager R; Neyts J Hepatology; 2006 Apr; 43(4):761-70. PubMed ID: 16557546 [TBL] [Abstract][Full Text] [Related]
20. Synthesis of 2-C-hydroxymethylribofuranosylpurines as potent anti-hepatitis C virus (HCV) agents. Yoo BN; Kim HO; Moon HR; Seol SK; Jang SK; Lee KM; Jeong LS Bioorg Med Chem Lett; 2006 Aug; 16(16):4190-4. PubMed ID: 16781148 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]